Carlsmed
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1800 Aston Ave Ste 100, Carlsbad, Califo...Phone Number
(760) 766-1923Website
www.carlsmed.comRevenue
$63.3 MillionStock Symbol
CARLIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Carlsmed
Carlsmed's mission is to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. The company's aprevo ® devices are personalized to improve the standard of care for the surgical treatment of adults with spinal malalignment. Carlsmed uses patient data and proprietary digital technologies to create aprevo ® spine fusion devices to align with the surgeon's goals for each patient.Explore more
Carlsmed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Carlsmed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Carlsmed
Funding: Get notified immidiatlly once Carlsmed has new funding data
Earning: See what the market has to say on Carlsmed recently announced quarterly report
Click to see if Carlsmed had a recent Job posting/layoffs
Check out if Carlsmed is spiking on competitors!
Carlsmed, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Carlsmed has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Carlsmed launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Carlsmed as Masked Content
Find 2 more new buyers
Compare Similar Companies to Carlsmed
Compare insights from companies similar to Carlsmed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Carlsmed is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Carlsmed is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Carlsmed.
Carlsmed financials insights
Gather financial insights about Carlsmed, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$2.5M
Series A
$10M
2022
Series B
$30M
2024
Series C
$52.5M
2025
IPO
$100M
Carlsmed Tech Stack
A closer look at the technologies used by Carlsmed
Most Recent Scoops
Open Position
Earnings
Carlsmed has reported a gross margin of approximately 77% for Q1 2026, increasing from 76% in H2 2025 and 74% in H1 2025, with the company citing AI-enabled efficiencies and fixed cost absorption as drivers of continued durability in the mid-to-high 70% range.
Earnings, Artificial Intelligence, Finance
Person-Based
Events, Healthcare Technology
Open Position
Person-Based
Executive Moves, Earnings, Finance
Carlsmed News & Media
Carlsmed Q2 Earnings Call Highlights
Carlsmed (NASDAQ:CARL) reported second-quarter 2026 revenue of $18.9 million, up 57% from $12.1 million a year earlier, as growth in its aprevo lumbar platform and contributions from its newer cervical offering lifted procedure volumes. Chairman and Chief Executive Officer Mike Cordonnier said theCarlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures
Centers for Medicare & Medicaid Services (CMS) Fiscal Year 2027 Inpatient Final Rule creates three new Medicare Severity-Diagnosis Related Groups (MS-DRGs), with favorable reimbursement for Carlsmed aprevo® Lumbar spine fusion procedures Centers for Medicare & Medicaid Services (CMS) Fiscal Year 2027 Inpatient Final Rule creates three new Medicare Severity-Diagnosis Related Groups (MS-DRGs), with favorable reimbursement for Carlsmed aprevo® Lumbar spine fusion proceduresCarlsmed, Inc. To Participate in Upcoming Investor Conferences
CARLSBAD, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions today announced that management will participate in the following investor conferences:Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026
CARLSBAD, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2026 financial results after market close on Wednesday, August 5, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Carlsmed
Sign Up For FreeTo access detailed company insights
Carlsmed's mission is to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. The company's aprevo ® devices are personalized to improve the standard of care for the surgical treatment of adults with spinal malalignment. Carlsmed uses patient data and proprietary digital technologies to create aprevo ® spine fusion dev... Read More
